Mass Vaccination with a New, Less Expensive Oral Cholera Vaccine Using Public Health Infrastructure in India: The Odisha Model

• Shantanu K. Kar,

  Affiliation Regional Medical Research Center, Bhubaneswar, Odisha, India

  ⨯
• Binod Sah ,

  * E-mail: Binod.Sah@ivi.int

  Affiliation International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• Bikash Patnaik,

  Affiliation Directorate of Health Services, Odisha, India

  ⨯
• Yang Hee Kim,

  Affiliation International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• Anna S. Kerketta,

  Affiliation Regional Medical Research Center, Bhubaneswar, Odisha, India

  ⨯
• Sunheang Shin,

  Affiliation International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• Shyam Bandhu Rath,

  Affiliation Regional Medical Research Center, Bhubaneswar, Odisha, India

  ⨯
• Mohammad Ali,

  Affiliation International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• Vittal Mogasale,

  Affiliation International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• Hemant K. Khuntia,

  Affiliation Regional Medical Research Center, Bhubaneswar, Odisha, India

  ⨯
• Anuj Bhattachan,

  Affiliation International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• Young Ae You,

  Affiliation International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• Mahesh K. Puri,

  Affiliation International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• Anna Lena Lopez,

  Affiliations International Vaccine Institute, Seoul, Republic of Korea, University of the Philippines Manila, National Institutes of Health, Manila, Philippines

  ⨯
• Brian Maskery,

  Affiliation International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• Gopinath B. Nair,

  Affiliation Translational Health Science and Technology Institute, Department of Biotechnology, New Delhi, India

  ⨯
• John D. Clemens,

  Affiliations International Vaccine Institute, Seoul, Republic of Korea, University of California, Los Angeles School of Public Health, Los Angeles, California, United States of America

  ⨯
•  [ ... ],
• Thomas F. Wierzba

  Affiliation International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• [ view all ]
• [ view less ]